Products for Research Use Only

IKP-104

CAT: 0804-HY-W854934Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W854934Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
IKP-104 is a microtubule/tubulin inhibitor (IC50 = 1.31 μM) . IKP-104 arrests cells in mitosis and the M phase by inhibiting microtubule polymerization and inducing cytoskeletal microtubule depolymerization. IKP-104 inhibits the growth of mouse and human tumor cell lines. IKP-104 exhibits anti-tumor effects in mouse ascites tumors and lung cancer models. IKP-104 is useful in the research of cancers such as leukemia, lung cancer and melanoma[1][2][3][4].
CAS Number
114231-14-0
UNSPSC
12352005
Target
Microtubule/Tubulin
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C1C(C)=C(C2=CC=C(F)C=C2)N(C3=CC(OC)=CC(OC)=C3Cl)C(C4=CC=CC=C4)=C1
Molecular Formula
C26H21ClFNO3
Molecular Weight
449.90
References & Citations
[1]Mizuhashi F, et al. Antitumor activities of IKP-104, a 4 (1H) -pyrizinone derivative, on cultured and implanted tumors. Jpn J Cancer Res. 1990 Dec;81 (12) :1300-6.|[2]Mizuhashi F, et al. Effects of the tumor inhibitor IKP-104, a 4 (1H) -pyridinone derivative, on cytoskeletal microtubules of cultured tumor cells. Jpn J Cancer Res. 1991 Dec;82 (12) :1442-7.|[3]Mizuhashi F, et al. Interaction of the tumor inhibitor IKP-104, a 4 (1H) -pyridinone derivative, with microtubule proteins. Jpn J Cancer Res. 1992 Feb;83 (2) :211-8.|[4]Khan IA, et al. Differential interaction of tubulin isotypes with the antimitotic compound IKP-104. Biochemistry. 2000 Aug 1;39 (30) :9001-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported